Home - Clinical Trials Arena
WEBKezar Life Sciences suspends subject enrolment in trial of lupus nephritis drug. According to the safety findings, four Grade Five serious adverse events were reported during the Phase II PALIZADE trial. News.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Saxenda (liraglutide) for the Treatment of Obesity, US
WEBAug 4, 2023 · Saxenda (liraglutide (rDNA origin)) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity for the treatment of obesity and chronic weight management.. Discovered and developed by Denmark-based pharmaceutical company Novo Nordisk, Saxenda is available as a solution in pre-filled, multi-dose pens that delivers ...
News - Clinical Trials Arena
WEBExscientia outline robot and AI use in drug discovery workflow. As AI continues to disrupt the healthcare industry, more pharma companies are using algorithms to design drug molecules. AI-driven pharma…. Jenna Philpott.
Top Ongoing mRNA Herpes Vaccine Trials - Clinical Trials Arena
WEBFeb 2, 2023 · Pfizer and Moderna eye seasonal influenza. The two largest mRNA vaccine trials with readouts in 2023 are for seasonal influenza. First up, Moderna’s 6,102-patient, Phase III trial of mRNA-1010 (NCT05415462) has immunogenicity data expected in Q1 2023. The trial is testing mRNA-1010 against an …
Schizophrenia: Four major clinical trials to watch in 2023
WEBApr 13, 2023 · Novel mechanisms and an overlooked symptom target highlight a slate of major schizophrenia clinical trials with readouts expected in 2023. William Newton April 13, 2023. Despite significant advances in understanding the neurobiology of schizophrenia, treatment options have largely remained limited. But in 2023, four late-stage clinical trial ...
Tesofensine Anti-Obesity Medication - Clinical Trials Arena
WEBDec 14, 2008 · Dose-dependent adverse gastrointestinal effects were observed with tesofensine in the clinical trials in addition to increases in blood pressure and heart. However, at the anticipated therapeutic dose of 0.5mg, discontinuations for adverse effects with tesofensine were similar to placebo (8%). In …
Reports - Clinical Trials Arena
WEBGlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the pharmaceuticals and healthcare market. Reports cover market growth forecasts, trends and research, and more. View all reports.
Medicine in outer space: drug development, manufacturing, and …
WEBOct 6, 2022 · With investment in space rising and humans on the cusp of travelling to Mars, scientists are developing new tools for testing and manufacturing medicines beyond our planet. William Newton October 6, 2022. In 2018, roughly a year before the World Health Organization declared Covid-19 a global health emergency, a conference in …
Ozempic (semaglutide) for the Treatment of Type 2 Diabetes
WEBOzempic ® (semaglutide) is a glucagon-like peptide (GLP-1) receptor agonist indicated for the treatment of Type 2 diabetes in adults. The drug was discovered and developed by Novo Nordisk, which submitted a new drug application (NDA) for the drug to the US Food and Drug Administration (FDA) under the Prescription Drug User Fee Act V (PDUFA V ...
- Some results have been removed